DRMADermata Therapeutics, Inc.

Nasdaq dermatarx.com


$ 4.50 $ -1.00 (-19.23 %)    

Friday, 17-May-2024 13:21:08 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 4.2
$ 4.67
$ 0.00 x 0
$ 0.00 x 0
$ 4.50 - $ 4.68
$ 3.48 - $ 40.50
58,001
na
1.87M
$ -17.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 09-27-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnolog...

 dermata-therapeutics-q1-2024-gaap-eps-047-misses-036-estimate

Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate o...

 dermata-therapeutics-fy23-eps-267-vs-1392-yoy

Full Year 2023 Financial ResultsAs of December 31, 2023, the Company had $7.4 million in cash and cash equivalents, compared to...

 why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Applied Therapeutics, Inc.

 dow-turns-lower-ism-services-pmi-falls-in-december

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded d...

 why-is-aesthetic-skin-conditions-focused-dermata-therapeutics-stock-trading-higher-today

Dermata Therapeutics Inc (NASDAQ: DRMA) stock was trading higher Friday after the company announced the issuance of a new paten...

 why-dermata-therapeutics-shares-are-trading-higher-by-over-57-here-are-20-stocks-moving-premarket

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuan...

 dermata-enrolls-first-patient-in-pivotal-dmt310-phase-3-star-1-clinical-trial-for-acne-about-550-patients-will-be-treated-once-weekly-for-12-weeks

- About 550 patients will be treated once weekly for 12 weeks -- STAR-1 topline results expected in first quarter of 2025 -- Ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION